DuPont de Nemours, Inc. (DD) — Q2 2026 Earnings Preview

Company

DuPont de Nemours, Inc.

Ticker

DD (NYSE)

Reporting Period

Q2 2026 (quarter ended June 30, 2026)

Earnings Date

August 4, 2026 — 8:00 AM ET

Prepared

August 3, 2026

1. Earnings Preview

Key Takeaway: Setup is constructive but not a layup — consensus sits essentially at guidance midpoint, leaving little room for error, and the single biggest swing factor is whether Water Technologies recovers as management expects in 2H after Middle East logistics disruptions weighed on Q1.

Heading into Q2 2026, the bar for DuPont is well-defined: management guided to ~$1.8B in net sales, ~$430M in operating EBITDA, and ~$0.59 in adjusted EPS, and consensus sits almost exactly at those levels ($1.81B / $432M / $0.60), meaning the print is essentially a pass/fail on execution rather than a beat-the-bar setup. Management's tone on the Q1 call was notably confident — they raised full-year guidance by $80M at the midpoint on net sales and $0.10 on EPS, launched a $275M ASR funded by Aramids proceeds, and characterized Middle East logistics disruptions as temporary and already resolved (the ~$10M of unshipped water volume had already moved in April). Estimate revisions since the Q1 print have been modest and directionally positive, with the FY 2026 operating EBITDA consensus ticking up slightly to ~$1.742B versus the $1.745B midpoint of guidance — a tight alignment that reflects Street confidence in the guide rather than independent upside. The stock has been essentially flat since the Q1 print (up ~1% over the past month, ~2% over three months), trading at ~11.7x NTM EV/EBITDA versus a prior 12.2x three months ago, suggesting multiple compression has absorbed some of the fundamental improvement and the stock is neither pricing in a big beat nor a miss. The key wildcard is Water Technologies in 2H: management guided to high-single-digit organic growth in H2 water (versus flat in H1) driven by large Middle East desalination project timing — if those projects slip or the conflict escalates further, the full-year organic growth assumption of ~4% comes under pressure and the stock could re-rate lower despite solid Healthcare execution.

2. KPIs & Consensus Expectations

Key Takeaway: Consensus is essentially at guidance midpoint — a low-cushion bar. Operating EBITDA margin is the bigger swing factor: a 30 bps price-cost headwind and 40 bps mix headwind from Q1 to Q2 are already embedded in guidance, but any incremental Middle East cost pressure or Water volume shortfall could compress margins below the ~23.9% implied by the guide.

Table 1 — Current Quarter Snapshot (Q2 2026)

KPI

Q1 2026 Actual

Q2 2025 Actual (Prior Year)

Q2 2026 Consensus Estimate

YoY Change

Q2 2026 Guidance (Mgmt)

Consensus vs. Guidance

Net Sales ($M)

$1,681M

$1,749M

$1,810M

+3.5% YoY

~$1,800M

+0.5% above midpoint

Operating EBITDA ($M)

$414M

$423M

$432M

+2.1% YoY

~$430M

+0.5% above midpoint

Adj. EPS — Diluted, Cont. Ops ($)

$1.65

$3.36 (pre-split)

$0.60

N/A (reverse split Jun-26)

~$0.59

+1.7% above midpoint

Organic Sales Growth (%)

+2.0%

+1.4%

~+3.0%

+160 bps YoY

~3%

At midpoint

Healthcare & Water Revenue ($M)

$806M

$817M

$857M

+4.9% YoY

Mid-SD organic growth guided

N/A — no $ guidance

Diversified Industrials Revenue ($M)

$875M

$932M

$951M

+2.0% YoY

Low-SD organic growth guided

N/A — no $ guidance

Sources: Visible Alpha consensus and actuals data (net sales, operating EBITDA, adj. EPS, organic growth, segment revenues). Q2 2026 guidance from DuPont Q1 2026 Earnings Release and Q1 2026 Earnings Call Transcript (May 5, 2026). Note: DD completed a 1-for-3 reverse stock split on June 24, 2026; all EPS figures for Q2 2026 and forward are on a post-split basis. Prior-period EPS figures are pre-split and not directly comparable.

Table 2 — Beat/Miss History (Last 8 Quarters, Top 2 KPIs)

Net Sales

Quarter

Reported ($M)

Consensus ($M)

Surprise %

Result

Q2 2024

$1,717M

N/A — pre-separation

N/A

N/A

Q3 2024

$1,714M

N/A — pre-separation

N/A

N/A

Q4 2024

$1,689M

N/A — pre-separation

N/A

N/A

Q1 2025

$1,612M

N/A — pre-separation

N/A

N/A

Q2 2025

$1,749M

N/A — pre-separation

N/A

N/A

Q3 2025

$1,795M

N/A — pre-separation

N/A

N/A

Q4 2025

$1,693M

$1,688M

+0.3%

Slight Beat

Q1 2026

$1,681M

$1,664M

+1.0%

Beat

Operating EBITDA

Quarter

Reported ($M)

Consensus ($M)

Surprise %

Result

Q2 2024

$400M

N/A — pre-separation

N/A

N/A

Q3 2024

$415M

N/A — pre-separation

N/A

N/A

Q4 2024

$395M

N/A — pre-separation

N/A

N/A

Q1 2025

$360M

N/A — pre-separation

N/A

N/A

Q2 2025

$423M

N/A — pre-separation

N/A

N/A

Q3 2025

$436M

N/A — pre-separation

N/A

N/A

Q4 2025

$409M

$385M

+6.2%

Beat

Q1 2026

$414M

$392M

+5.6%

Beat

Pattern: For the two quarters with clean standalone consensus data (Q4 2025 and Q1 2026), DuPont has beaten operating EBITDA consensus by an average of ~6%, driven by better-than-expected mix and productivity. Prior quarters lack comparable standalone consensus given the Qnity Electronics separation completed in late 2025. Source: Visible Alpha consensus and actuals data.

3. Guidance & Commentary Evolution

Key Takeaway: Management raised full-year guidance at Q1 earnings (May 5) and has not issued any subsequent update — the Q2 guide is unchanged from what was communicated on the Q1 call. Tone remains confident, with the Aramids divestiture closed and ASR launched.

Metric

Initial Guidance (Q1 2026 Earnings Call, May 5, 2026)

Revised Guidance

Current Consensus

Note

Q2 2026 Net Sales

~$1,800M

$1,810M

No post-earnings update; consensus +0.5% above midpoint

Q2 2026 Operating EBITDA

~$430M

$432M

No post-earnings update; consensus +0.5% above midpoint

Q2 2026 Adj. EPS

~$0.59

$0.60

No post-earnings update; consensus +1.7% above midpoint

Q2 2026 Organic Growth

~3%

~3.0%

At midpoint; H&W mid-SD, DI low-SD guided

FY 2026 Net Sales

$7,155–$7,215M (raised from prior guide)

$7,018M

Consensus ~2.3% below midpoint; reflects Aramids removal from consolidation

FY 2026 Operating EBITDA

$1,730–$1,760M (raised from prior guide)

$1,742M

Consensus at midpoint; tight alignment

FY 2026 Adj. EPS

$2.35–$2.40 (raised $0.10 vs. prior guide)

$2.39

Consensus near top of range; includes Aramids interest income benefit

FY 2026 Organic Growth

~4% (incl. ~1% pricing for Middle East cost offset)

~3.6%

Consensus slightly below guide; reflects some skepticism on H2 Water recovery

Source: DuPont Q1 2026 Earnings Release and Earnings Call Transcript (May 5, 2026); Visible Alpha consensus data. Note: The 1-for-3 reverse stock split completed June 24, 2026 affects share count and per-share metrics; all EPS figures above are on a post-split basis.

4. Guidance vs. Estimate Revision Tracker

Key Takeaway: Estimates have been broadly stable-to-slightly-positive since the Q1 print, tracking guidance closely. The FY 2026 operating EBITDA consensus has barely moved, suggesting the Street is comfortable with the guide but not adding incremental upside. The modest gap between consensus and guidance on organic growth is the one area where the Street is not fully buying the H2 Water recovery story.

KPI & Period

Estimate ~5 Days Post Q1 Earnings (as of ~May 12, 2026)

Current Consensus

Estimate Δ (%)

Initial Guidance (Q1 Call)

Current Guidance

Guidance Δ

Consensus vs. Guidance (%)

Net Sales — Q2 2026

$1,806M

$1,810M

+0.2%

~$1,800M

~$1,800M (unchanged)

Flat

+0.5%

Operating EBITDA — Q2 2026

$431M

$432M

+0.2%

~$430M

~$430M (unchanged)

Flat

+0.5%

Adj. EPS — Q2 2026

N/A (split-adjusted; limited as-of data)

$0.60

N/A

~$0.59

~$0.59 (unchanged)

Flat

+1.7%

Net Sales — FY 2026

$7,002M

$7,018M

+0.2%

$7,155–$7,215M

$7,155–$7,215M (unchanged)

Flat

-2.3% vs. midpoint

Operating EBITDA — FY 2026

$1,741M

$1,742M

+0.1%

$1,730–$1,760M

$1,730–$1,760M (unchanged)

Flat

-0.2% vs. midpoint

Source: Visible Alpha consensus and actuals data (as-of May 12, 2026 baseline and current consensus). Guidance from DuPont Q1 2026 Earnings Call Transcript (May 5, 2026). The FY 2026 net sales consensus gap vs. guidance midpoint (~-2.3%) reflects the Street’s treatment of Aramids divestiture proceeds and segment reclassification rather than fundamental skepticism on organic growth. Operating EBITDA consensus is essentially at the guidance midpoint, confirming tight alignment.

5. Stock Performance

Key Takeaway: The 12-month +57% gain was driven by a combination of earnings growth and modest multiple expansion (+12% on EV/EBITDA), but the past 6 months tell a different story — the stock is up only +7% while the NTM EV/EBITDA multiple has compressed 23% (from 15.3x to 11.7x), meaning the fundamental improvement has been more than offset by de-rating. Near-term, the stock is essentially flat (up ~1% over 1 month and ~2% over 3 months) with further multiple compression of ~1-4%, suggesting the market is in a “show me” mode ahead of the print.

Stock Performance Decomposition (NTM EV/EBITDA)

Horizon

Price Change

NTM EV/EBITDA (Start)

NTM EV/EBITDA (Current)

Multiple Change

Driver

1 Month

+1.0%

11.84x

11.67x

-1.4%

Earnings growth offset by slight de-rating

3 Months

+1.9%

12.15x

11.67x

-3.9%

Earnings growth more than offset by multiple compression

6 Months

+7.3%

15.26x

11.67x

-23.5%

Significant de-rating post-Qnity separation; earnings growth partially offset

12 Months

+56.6%

10.42x

11.67x

+12.1%

Strong earnings growth + modest re-rating; bulk of gain is fundamental

Source: Implied stock performance decomposition tool (snapshot August 3, 2026). Current NTM EV/EBITDA: 11.67x. The 6-month multiple compression from 15.3x to 11.7x reflects the market adjusting to the smaller, standalone DuPont post-Qnity Electronics separation (completed late 2025) and the Aramids divestiture (April 1, 2026). At 11.7x NTM EV/EBITDA, DD trades at a meaningful discount to multi-industrial peers, consistent with management’s stated goal of achieving a GICS reclassification to multi-industrial to close the valuation gap.

6. Material News & Developments (Since Q1 2026 Earnings, May 5, 2026)

Key Takeaway: The most important development is the 1-for-3 reverse stock split completed June 24, which is a structural/cosmetic event with no fundamental impact but affects per-share comparisons. The Aramids divestiture close (April 1) and $275M ASR launch are the key capital allocation signals heading into the print.

7. Insider Transaction Activity

Key Takeaway: No open-market insider buys or discretionary sells were identified for DD in the period since the Q1 2026 earnings release (May 5, 2026 through August 3, 2026). The absence of insider activity is not unusual given the reverse stock split mechanics and the typical quiet period ahead of earnings. Nothing stands out as a signal.

Name

Title

Transaction Type

Value

Date

Note

No reportable open-market transactions identified for DD in the post-Q1 window (May 5 – August 3, 2026).

Source: SEC Form 4 insider transactions database, queried for DD, May 5 – August 3, 2026, open-market buy (code P) and sell (code S) transactions. No transactions returned. The company is in a standard pre-earnings quiet period.

8. Peer Commentary Read-Throughs (Last 60 Days — Q2 2026 Reporting Period)

Key Takeaway: Peers reporting Q2 2026 results paint a broadly constructive but nuanced picture for DuPont: specialty/differentiated businesses with pricing power are outperforming; construction/housing remains weak; aerospace is a standout; and the Middle East conflict is creating both cost headwinds (feedstocks, logistics) and, for some, supply-driven pricing tailwinds. The read-through for DD is net positive on Healthcare and Aerospace, cautious on construction, and mixed on Water (logistics disruptions persisting but large project pipeline intact).

Note: Only commentary explicitly addressing Q2 2026 results or the current reporting quarter outlook is included below. Prior-quarter results commentary has been excluded.

DOW — Q2 2026 Earnings (Reported July 23, 2026)

DOW reported Q2 2026 adj. EPS of $1.44 vs. consensus of $1.31, with net sales of $12.09B and EBITDA of $2.3B, both slightly ahead of estimates. Management is increasing its cost savings target from restructuring by ~$200M. Q3 EBITDA guidance of $1.75B fell slightly short of Street expectations of $1.86B.

Key Read-Throughs for DD:

EMN (Eastman Chemical) — Q2 2026 Earnings (Reported July 30, 2026)

EMN reported Q2 2026 results with solid volume and mixed growth in Advanced Materials (+5% organic), robust volume growth in Chemical Intermediates, and strong pricing execution. Revenue is expected to be ~$500M higher for the full year due to pricing actions.

Key Read-Throughs for DD:

HUN (Huntsman) — Q2 2026 Earnings (Reported July 30–31, 2026)

HUN reported a Q2 EPS miss but sales and EBITDA were slightly ahead of plan. The company delivered higher volumes across all three segments and pricing actions that offset a significant increase in raw material costs. Advanced Materials grew 8% and Polyurethanes grew 4% organically.

Key Read-Throughs for DD:

LYB (LyondellBasell) — Q2 2026 Earnings (Reported July 31, 2026)

LYB reported Q2 2026 EBITDA of $2.12B, significantly exceeding Street expectations of $1.78B, benefiting from Middle East conflict-driven supply disruptions that tightened global polyolefin markets and drove record price increases. The company characterized market normalization as “a long process extending beyond 2026.”

Key Read-Throughs for DD:

PPG — Q2 2026 Earnings (Reported July 28–29, 2026)

PPG reported Q2 2026 adj. EPS of $2.23, slightly missing the Street estimate of $2.25, and reiterated (rather than raised) its EPS guidance. The company delivered its sixth consecutive quarter of organic sales growth at +4%, outpacing the industry by 300 bps. PPG covered ~90% of COGS inflation with pricing in Q2 and expects 100% coverage by Q4.

Key Read-Throughs for DD:

Peer Read-Through Summary Table

Theme

DOW

EMN

HUN

LYB

PPG

DD Implication

Middle East / Logistics Disruption

⚠️ Ongoing

⚠️ Cost flow-through

⚠️ Surcharges needed

⚠️ Freight surge

⚠️ RAW above plan

Validates DD cost assumptions; risk of incremental pressure

Specialty Pricing Power

✅ Strong

✅ Tailwind in H2

✅ Surcharges working

N/A (commodity)

✅ 90% coverage

Positive: DD’s ~$25M Q2 price plan is achievable

Aerospace

✅ EV/mobility strong

✅ Stable, new products

✅ Recovery + new apps

N/A

✅ Double-digit growth

Strong positive: aerospace upcycle intact for DD Industrial Tech

Construction / Housing

❌ Soft, seasonal declines

N/A

❌ Housing didn’t take off

❌ Stable but subdued

⚠️ Mixed by region

Consistent with DD’s flat construction guide; no upside catalyst

Data Center / Electronics

✅ Demand outpacing supply

✅ Semis growing fast

✅ Power/grid buildout

✅ Very strong demand

✅ Pipeline robust

Strong positive: DD Water ion exchange / microelectronics well-positioned

Healthcare / Water Demand

N/A

✅ Water treatment stable

N/A

✅ Healthcare resilient

N/A

Positive: underlying demand for DD’s H&W segment is intact

Automotive / EV

✅ Double-digit EV growth

⚠️ Weak OEM/durables

✅ EV new apps growing

⚠️ Stable but softer

✅ Refinish destocking done

Mixed: EV positive for DD battery adhesives; OEM/durables soft

Sources: DOW Q2 2026 Earnings Call Transcript (July 23, 2026); EMN Q2 2026 Earnings Call Transcript (July 30–31, 2026); HUN Q2 2026 Earnings Call Transcript (July 30–31, 2026); LYB Q2 2026 Earnings Call Transcript (July 31, 2026); PPG Q2 2026 Earnings Call Transcript (July 28–29, 2026). All commentary is from Q2 2026 reporting period only; prior-quarter results commentary excluded per user instruction.